A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients

A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients

Bibliographic Details
Main Authors: Nishina, Tomohiro, Takano, Yoshinao, Denda, Tadamichi, Yasui, Hisateru, Takeda, Koji, Ura, Takashi, Esaki, Taito, Okuyama, Yusuke, Kondo, Ken, Takahashi, Yasuo, Sugiyama, Yasuyuki, Muro, Kei
Format: Online
Language:English
Published: Oxford University Press 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814899/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814899/

Similar Items